Differences between revisions 5 and 6
Revision 5 as of 2008-07-17 13:38:22
Size: 1194
Editor: GaryBader
Comment:
Revision 6 as of 2008-07-17 14:25:49
Size: 1574
Editor: GaryBader
Comment:
Deletions are marked like this. Additions are marked like this.
Line 13: Line 13:
 * Trey Ideker
 * Gary Bader
 * Annette Adler
 * Alex Pico (in lieu of Bruce)
 * Benno Schwikowski
 * Chris Sander
 * Charlie Boone
 * Mark Gerstein
 * Shoshana Wodak
 * Trey Ideker (University of California, San Diego)
 * Gary Bader (University of Toronto)
 * Annette Adler (Agilent Technologies, San Francisco Bay area)
 * Alex Pico (in lieu of Bruce Conklin) (Gladstone Institute of Cardiovascular Disease, UCSF, San Francisco)
 * Benno Schwikowski (Institut Pasteur, Paris)
 * Chris Sander (Memorial Sloan-Kettering Cancer Center, New York)
 * Charlie Boone (University of Toronto)
 * Mark Gerstein (Yale University)
 * Shoshana Wodak (Hospital for Sick Children, Toronto)
 * Yeyejide Adeleye (Unilever, UK)

Cytoscape Board Meeting

Description

This is a private meeting of the Cytoscape board of directors and scientific advisory board members to discuss Cytoscape strategy, funding and scientific directions.

Attendees

  • Trey Ideker (University of California, San Diego)
  • Gary Bader (University of Toronto)
  • Annette Adler (Agilent Technologies, San Francisco Bay area)
  • Alex Pico (in lieu of Bruce Conklin) (Gladstone Institute of Cardiovascular Disease, UCSF, San Francisco)
  • Benno Schwikowski (Institut Pasteur, Paris)
  • Chris Sander (Memorial Sloan-Kettering Cancer Center, New York)
  • Charlie Boone (University of Toronto)
  • Mark Gerstein (Yale University)
  • Shoshana Wodak (Hospital for Sick Children, Toronto)
  • Yeyejide Adeleye (Unilever, UK)

Agenda

  • Update on Cytoscape (Mike Smoot)
  • New secretary/treasurer (Annette)
  • Cytoscape book - what's the goal? (Annette)
  • Funding (Trey)
  • Scientific directions

Notes

CytoscapeRetreat2008/BoardMeeting (last edited 2009-02-12 01:03:27 by localhost)

Funding for Cytoscape is provided by a federal grant from the U.S. National Institute of General Medical Sciences (NIGMS) of the Na tional Institutes of Health (NIH) under award number GM070743-01. Corporate funding is provided through a contract from Unilever PLC.

MoinMoin Appliance - Powered by TurnKey Linux